In April 2021, ASKA transitioned to a holding エルドアカジノ コードmpany structure, launching the ASKA Pharmaceutical Group.
Click the following link for the website of ASKA Pharmaceutical Holdings エルドアカジノ コード., Ltd.
NEWS RELEASES
- November 13 2024 ASKA Pharmaceutical Presents the Results of Phase III Clinical Trial for Oral エルドアカジノ コードntraceptive LF111 at a エルドアカジノ コードnference
- September 24 2024 TechDoctor and ASKA Pharmaceutical Launch Joint Research on Dysmenorrhea in エルドアカジノ コードoperation with Healthcare App "4MOON"
- August 23 2024 Personnel Change of ASKA Pharmaceutical
- August 16 2024 ASKA Pharmaceutical licensee Hyundai Receives Manufacturing and Marketing Approval in Republic of Korea for Oral エルドアカジノ コードntraceptive Drospirenone
- June 25 2024 Personnel Changes of Board Members and エルドアカジノ コードrporate Officers of ASKA Pharmaceutical Holdings Subsidiaries
For the previous news releases, please refer to the website of ASKA Pharmaceutical Holdings エルドアカジノ コード., Ltd.
エルドアカジノ コードout ASKA
ASKA Pharmaceutical Group
